HLA class I and II genotype of the NCI-60 cell lines
<p>Abstract</p> <p>Sixty cancer cell lines have been extensively characterized and used by the National Cancer Institute's Developmental Therapeutics Program (NCI-60) since the early 90's as screening tools for anti-cancer drug development. An extensive database has been...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-03-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/3/1/11 |